Advancing Health-Related SDGs In Africa Through Private Sector Collaborations 25/10/2019 Thomas B. Cueni As the World Health Summit opens Sunday in Berlin, one of the key themes running through the conference will be how industry, government and civil society leaders can collaborate more effectively to build strong health institutions – with a particular focus on building African capacities in a Monday keynote session. This means working across all […] Continue reading -> G20 Health Ministers Issue Detailed Declaration On Global Health Goals 22/10/2019 Elaine Ruth Fletcher A G20 Health Ministers Declaration, issued after a two-day meeting of ministers in Okayama Japan, has endorsed rapid achievement of universal health coverage, a more effective support of healthy ageing, increased attention to health emergencies and their underlying causes such as poverty and weak health systems, and more forceful action on antimicrobial resistance (AMR). The […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Measles Resurgence, Polio Persistence & HPV Vaccine Shortages Concern Health Experts 11/10/2019 Elaine Ruth Fletcher Measles is undergoing a worrisome worldwide resurgence, and it has killed more people in the Democratic Republic of Congo than the current Ebola outbreak – which is finally showing signs of decline, said a panel of vaccine experts in a WHO press briefing on Thursday. Meanwhile, a worldwide shortage of human papillomavirus (HPV) vaccine, which […] Continue reading -> The Medicines Patent Pool Publishes Intellectual Property Status Of 18 Drugs Added To WHO Essential Medicines List 03/10/2019 Press release [The Medicines Patent Pool] Geneva (2 October 2019) — The Medicines Patent Pool today announced the first of a two-step update of its database MedsPaL to include additional patented small molecule medicines following the publication of the World Health Organization (WHO)’s updated Model List of Essential Medicines (EML) in July. Launched in 2016, MedsPaL is […] Continue reading -> Europe’s Gastein Forum: ‘Healthy Disruption’ To Tackle Inequalities, Promote Well-Being 29/09/2019 Elaine Ruth Fletcher The 2019 European Health Forum (Gastein) opens Wednesday under this year’s theme: “A Healthy Dose of Disruption.” The three-day Forum will explore ways in which Europe can transform health systems into levers of good health and well-being, guided by the aspirations of the recent UN declaration on Universal Health Coverage. Since its foundation in 1998, […] Continue reading -> Antimicrobial Resistance Rising Fast In Livestock of Developing World 27/09/2019 Grace Ren Antimicrobial resistance (AMR) is emerging fast in livestock in the developing world, with northeast India and northern China among the most worrisome “hotspots”, says a first-ever study mapping AMR in low and middle-income countries, published this week in Science. Parts of Turkey, Kenya, Brazil, Egypt, Vietnam and South Africa were also noted as areas of high […] Continue reading -> Universal Health Coverage Requires More Policy-Relevant Research 26/09/2019 Grace Ren NEW YORK CITY – Evidence-based decision-making and tapping into local potential are keys to achieving the goals set in the Universal Health Coverage (UHC) declaration, said a panel convened today on the sidelines of the 74th United Nations General Assembly. The Government of Georgia, whose Permanent Mission to the UN co-sponsored the panel, helped lead […] Continue reading -> Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts
G20 Health Ministers Issue Detailed Declaration On Global Health Goals 22/10/2019 Elaine Ruth Fletcher A G20 Health Ministers Declaration, issued after a two-day meeting of ministers in Okayama Japan, has endorsed rapid achievement of universal health coverage, a more effective support of healthy ageing, increased attention to health emergencies and their underlying causes such as poverty and weak health systems, and more forceful action on antimicrobial resistance (AMR). The […] Continue reading -> Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Measles Resurgence, Polio Persistence & HPV Vaccine Shortages Concern Health Experts 11/10/2019 Elaine Ruth Fletcher Measles is undergoing a worrisome worldwide resurgence, and it has killed more people in the Democratic Republic of Congo than the current Ebola outbreak – which is finally showing signs of decline, said a panel of vaccine experts in a WHO press briefing on Thursday. Meanwhile, a worldwide shortage of human papillomavirus (HPV) vaccine, which […] Continue reading -> The Medicines Patent Pool Publishes Intellectual Property Status Of 18 Drugs Added To WHO Essential Medicines List 03/10/2019 Press release [The Medicines Patent Pool] Geneva (2 October 2019) — The Medicines Patent Pool today announced the first of a two-step update of its database MedsPaL to include additional patented small molecule medicines following the publication of the World Health Organization (WHO)’s updated Model List of Essential Medicines (EML) in July. Launched in 2016, MedsPaL is […] Continue reading -> Europe’s Gastein Forum: ‘Healthy Disruption’ To Tackle Inequalities, Promote Well-Being 29/09/2019 Elaine Ruth Fletcher The 2019 European Health Forum (Gastein) opens Wednesday under this year’s theme: “A Healthy Dose of Disruption.” The three-day Forum will explore ways in which Europe can transform health systems into levers of good health and well-being, guided by the aspirations of the recent UN declaration on Universal Health Coverage. Since its foundation in 1998, […] Continue reading -> Antimicrobial Resistance Rising Fast In Livestock of Developing World 27/09/2019 Grace Ren Antimicrobial resistance (AMR) is emerging fast in livestock in the developing world, with northeast India and northern China among the most worrisome “hotspots”, says a first-ever study mapping AMR in low and middle-income countries, published this week in Science. Parts of Turkey, Kenya, Brazil, Egypt, Vietnam and South Africa were also noted as areas of high […] Continue reading -> Universal Health Coverage Requires More Policy-Relevant Research 26/09/2019 Grace Ren NEW YORK CITY – Evidence-based decision-making and tapping into local potential are keys to achieving the goals set in the Universal Health Coverage (UHC) declaration, said a panel convened today on the sidelines of the 74th United Nations General Assembly. The Government of Georgia, whose Permanent Mission to the UN co-sponsored the panel, helped lead […] Continue reading -> Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts
Drug Pricing Transparency To Be Discussed At World Trade Organization 17/10/2019 Grace Ren A request by South Africa to the World Trade Organization (WTO) TRIPS Council to “address the transparency of R&D costs and pricing of medicines and health technologies” is expected to be reviewed Friday, 18 October 2019 as the TRIPS Council meets this week for its third session this year. The TRIPS Council, the administrative body […] Continue reading -> Measles Resurgence, Polio Persistence & HPV Vaccine Shortages Concern Health Experts 11/10/2019 Elaine Ruth Fletcher Measles is undergoing a worrisome worldwide resurgence, and it has killed more people in the Democratic Republic of Congo than the current Ebola outbreak – which is finally showing signs of decline, said a panel of vaccine experts in a WHO press briefing on Thursday. Meanwhile, a worldwide shortage of human papillomavirus (HPV) vaccine, which […] Continue reading -> The Medicines Patent Pool Publishes Intellectual Property Status Of 18 Drugs Added To WHO Essential Medicines List 03/10/2019 Press release [The Medicines Patent Pool] Geneva (2 October 2019) — The Medicines Patent Pool today announced the first of a two-step update of its database MedsPaL to include additional patented small molecule medicines following the publication of the World Health Organization (WHO)’s updated Model List of Essential Medicines (EML) in July. Launched in 2016, MedsPaL is […] Continue reading -> Europe’s Gastein Forum: ‘Healthy Disruption’ To Tackle Inequalities, Promote Well-Being 29/09/2019 Elaine Ruth Fletcher The 2019 European Health Forum (Gastein) opens Wednesday under this year’s theme: “A Healthy Dose of Disruption.” The three-day Forum will explore ways in which Europe can transform health systems into levers of good health and well-being, guided by the aspirations of the recent UN declaration on Universal Health Coverage. Since its foundation in 1998, […] Continue reading -> Antimicrobial Resistance Rising Fast In Livestock of Developing World 27/09/2019 Grace Ren Antimicrobial resistance (AMR) is emerging fast in livestock in the developing world, with northeast India and northern China among the most worrisome “hotspots”, says a first-ever study mapping AMR in low and middle-income countries, published this week in Science. Parts of Turkey, Kenya, Brazil, Egypt, Vietnam and South Africa were also noted as areas of high […] Continue reading -> Universal Health Coverage Requires More Policy-Relevant Research 26/09/2019 Grace Ren NEW YORK CITY – Evidence-based decision-making and tapping into local potential are keys to achieving the goals set in the Universal Health Coverage (UHC) declaration, said a panel convened today on the sidelines of the 74th United Nations General Assembly. The Government of Georgia, whose Permanent Mission to the UN co-sponsored the panel, helped lead […] Continue reading -> Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts
Measles Resurgence, Polio Persistence & HPV Vaccine Shortages Concern Health Experts 11/10/2019 Elaine Ruth Fletcher Measles is undergoing a worrisome worldwide resurgence, and it has killed more people in the Democratic Republic of Congo than the current Ebola outbreak – which is finally showing signs of decline, said a panel of vaccine experts in a WHO press briefing on Thursday. Meanwhile, a worldwide shortage of human papillomavirus (HPV) vaccine, which […] Continue reading -> The Medicines Patent Pool Publishes Intellectual Property Status Of 18 Drugs Added To WHO Essential Medicines List 03/10/2019 Press release [The Medicines Patent Pool] Geneva (2 October 2019) — The Medicines Patent Pool today announced the first of a two-step update of its database MedsPaL to include additional patented small molecule medicines following the publication of the World Health Organization (WHO)’s updated Model List of Essential Medicines (EML) in July. Launched in 2016, MedsPaL is […] Continue reading -> Europe’s Gastein Forum: ‘Healthy Disruption’ To Tackle Inequalities, Promote Well-Being 29/09/2019 Elaine Ruth Fletcher The 2019 European Health Forum (Gastein) opens Wednesday under this year’s theme: “A Healthy Dose of Disruption.” The three-day Forum will explore ways in which Europe can transform health systems into levers of good health and well-being, guided by the aspirations of the recent UN declaration on Universal Health Coverage. Since its foundation in 1998, […] Continue reading -> Antimicrobial Resistance Rising Fast In Livestock of Developing World 27/09/2019 Grace Ren Antimicrobial resistance (AMR) is emerging fast in livestock in the developing world, with northeast India and northern China among the most worrisome “hotspots”, says a first-ever study mapping AMR in low and middle-income countries, published this week in Science. Parts of Turkey, Kenya, Brazil, Egypt, Vietnam and South Africa were also noted as areas of high […] Continue reading -> Universal Health Coverage Requires More Policy-Relevant Research 26/09/2019 Grace Ren NEW YORK CITY – Evidence-based decision-making and tapping into local potential are keys to achieving the goals set in the Universal Health Coverage (UHC) declaration, said a panel convened today on the sidelines of the 74th United Nations General Assembly. The Government of Georgia, whose Permanent Mission to the UN co-sponsored the panel, helped lead […] Continue reading -> Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts
The Medicines Patent Pool Publishes Intellectual Property Status Of 18 Drugs Added To WHO Essential Medicines List 03/10/2019 Press release [The Medicines Patent Pool] Geneva (2 October 2019) — The Medicines Patent Pool today announced the first of a two-step update of its database MedsPaL to include additional patented small molecule medicines following the publication of the World Health Organization (WHO)’s updated Model List of Essential Medicines (EML) in July. Launched in 2016, MedsPaL is […] Continue reading -> Europe’s Gastein Forum: ‘Healthy Disruption’ To Tackle Inequalities, Promote Well-Being 29/09/2019 Elaine Ruth Fletcher The 2019 European Health Forum (Gastein) opens Wednesday under this year’s theme: “A Healthy Dose of Disruption.” The three-day Forum will explore ways in which Europe can transform health systems into levers of good health and well-being, guided by the aspirations of the recent UN declaration on Universal Health Coverage. Since its foundation in 1998, […] Continue reading -> Antimicrobial Resistance Rising Fast In Livestock of Developing World 27/09/2019 Grace Ren Antimicrobial resistance (AMR) is emerging fast in livestock in the developing world, with northeast India and northern China among the most worrisome “hotspots”, says a first-ever study mapping AMR in low and middle-income countries, published this week in Science. Parts of Turkey, Kenya, Brazil, Egypt, Vietnam and South Africa were also noted as areas of high […] Continue reading -> Universal Health Coverage Requires More Policy-Relevant Research 26/09/2019 Grace Ren NEW YORK CITY – Evidence-based decision-making and tapping into local potential are keys to achieving the goals set in the Universal Health Coverage (UHC) declaration, said a panel convened today on the sidelines of the 74th United Nations General Assembly. The Government of Georgia, whose Permanent Mission to the UN co-sponsored the panel, helped lead […] Continue reading -> Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts
Europe’s Gastein Forum: ‘Healthy Disruption’ To Tackle Inequalities, Promote Well-Being 29/09/2019 Elaine Ruth Fletcher The 2019 European Health Forum (Gastein) opens Wednesday under this year’s theme: “A Healthy Dose of Disruption.” The three-day Forum will explore ways in which Europe can transform health systems into levers of good health and well-being, guided by the aspirations of the recent UN declaration on Universal Health Coverage. Since its foundation in 1998, […] Continue reading -> Antimicrobial Resistance Rising Fast In Livestock of Developing World 27/09/2019 Grace Ren Antimicrobial resistance (AMR) is emerging fast in livestock in the developing world, with northeast India and northern China among the most worrisome “hotspots”, says a first-ever study mapping AMR in low and middle-income countries, published this week in Science. Parts of Turkey, Kenya, Brazil, Egypt, Vietnam and South Africa were also noted as areas of high […] Continue reading -> Universal Health Coverage Requires More Policy-Relevant Research 26/09/2019 Grace Ren NEW YORK CITY – Evidence-based decision-making and tapping into local potential are keys to achieving the goals set in the Universal Health Coverage (UHC) declaration, said a panel convened today on the sidelines of the 74th United Nations General Assembly. The Government of Georgia, whose Permanent Mission to the UN co-sponsored the panel, helped lead […] Continue reading -> Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts
Antimicrobial Resistance Rising Fast In Livestock of Developing World 27/09/2019 Grace Ren Antimicrobial resistance (AMR) is emerging fast in livestock in the developing world, with northeast India and northern China among the most worrisome “hotspots”, says a first-ever study mapping AMR in low and middle-income countries, published this week in Science. Parts of Turkey, Kenya, Brazil, Egypt, Vietnam and South Africa were also noted as areas of high […] Continue reading -> Universal Health Coverage Requires More Policy-Relevant Research 26/09/2019 Grace Ren NEW YORK CITY – Evidence-based decision-making and tapping into local potential are keys to achieving the goals set in the Universal Health Coverage (UHC) declaration, said a panel convened today on the sidelines of the 74th United Nations General Assembly. The Government of Georgia, whose Permanent Mission to the UN co-sponsored the panel, helped lead […] Continue reading -> Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts
Universal Health Coverage Requires More Policy-Relevant Research 26/09/2019 Grace Ren NEW YORK CITY – Evidence-based decision-making and tapping into local potential are keys to achieving the goals set in the Universal Health Coverage (UHC) declaration, said a panel convened today on the sidelines of the 74th United Nations General Assembly. The Government of Georgia, whose Permanent Mission to the UN co-sponsored the panel, helped lead […] Continue reading -> Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts
Building the Back End of Health Care Finance & Access to Cancer Treatment 24/09/2019 Elaine Ruth Fletcher If Fernando Arnaiz of Roche Pharmaceuticals had his way, the power of Kenyan mobile phone banking might soon be harnessed to health insurance schemes to finance treatment for cancer and other noncommunicable (NCDs) diseases, treatments accessible to only a tiny proportion of people in Africa today. Arnaiz is part of a unique team at Roche […] Continue reading -> Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts
Over Half of New Cancer Drugs Approved Based On Potentially Biased Evidence, New Study Finds 19/09/2019 Grace Ren NEW YORK – Over half of new cancer drug approvals granted by European authorities between 2014-2016 may have been made based on evidence from biased clinical trials, according to a new study published in The BMJ. The study, led by Dr. Christopher Booth, professor of oncology from Queens University Cancer Research Institute, raises serious questions […] Continue reading -> Posts navigation Older postsNewer posts